Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice and Revision: v3.4.1. These are administrative updates to the site and do not alter study details or eligibility information.
    Difference
    0.4%
    Check dated 2026-02-11T02:51:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new site-wide notice about a lapse in government funding appears on the page, and the revision tag shows v3.4.1 replacing the prior v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:48:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata labels (including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data'); revision updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T22:41:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no modifications to core study content, eligibility criteria, contact information, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:33:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Locations section now lists Santa Monica, California as a study site. The old California Locations block and the HHS Vulnerability Disclosure link were removed, and the revision tag updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:57:46.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.1%
    Check dated 2025-12-01T16:31:26.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.